This is an educational tool — it is not a prediction of future returns and should not be interpreted as investment advice. Methodology · Terms of Service →

DGXQuest Diagnostics Incorporated

stock · Healthcare

Factor Scores

BalancedStrong

+63.0%

Confidence: HIGH

ValueStrong

+55.5%

Confidence: HIGH

GrowthStrong

+46.0%

Confidence: HIGH

QualityStrong

+54.9%

Confidence: HIGH

GARPStrong

+50.4%

Confidence: HIGH

MomentumStrong

+61.5%

Confidence: HIGH

Analysis Notes

•At the current price, the model estimates approximately 9.9% annual earnings growth is priced in over 10 years (assuming a 10% discount rate). The 3-year trailing EDGAR EPS CAGR is 7.8% — the implied rate is 2.1pp above the historical trajectory.